Cargando…
Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: A review of the literature
BACKGROUND: Visual hallucinations occur in various neurological diseases, but are most prominent in Lewy body dementia, Parkinson's disease and schizophrenia. The lifetime prevalence of visual hallucinations in patients with schizophrenia is much more common than conventionally thought and rang...
Autores principales: | Patel, Sachin S, Attard, Azizah, Jacobsen, Pamela, Shergill, Sukhi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940862/ https://www.ncbi.nlm.nih.gov/pubmed/20822517 http://dx.doi.org/10.1186/1471-244X-10-69 |
Ejemplares similares
-
Acetylcholinesterase Inhibitors (AChEI's) for the treatment of visual hallucinations in schizophrenia: a case report
por: Patel, Sachin S, et al.
Publicado: (2010) -
De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer’s Agents
por: Pandey, Surabhi, et al.
Publicado: (2020) -
Treatment of Visual Hallucinations in Schizophrenia by Acetylcholinesterase Inhibitors: a case report
por: Abad, Nazir Hashemi, et al.
Publicado: (2011) -
Musical Hallucinations Treated with Acetylcholinesterase Inhibitors
por: Blom, Jan Dirk, et al.
Publicado: (2015) -
Targeting Treatment-Resistant Auditory Verbal Hallucinations in Schizophrenia with fMRI-Based Neurofeedback – Exploring Different Cases of Schizophrenia
por: Dyck, Miriam S., et al.
Publicado: (2016)